Join to view full profile
8901 Wisconsin AveBldg 8, Rm 5101Bethesda, MD 20889
Phone+1 301-496-0901
Fax+1 301-496-0047
Dr. Wedam is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 1997 - 2001
Georgetown University School of MedicineClass of 1997
Certifications & Licensure
VA State Medical License 1998 - 2028
DC State Medical License 1999 - 2000
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsCardiac Adverse Events in Patients Receiving Immune Checkpoint Inhibitors in the Adjuvant Setting: An FDA Pooled Analysis.Asma Dilawari, Mori J Krantz, Ilynn Bulatao, Hee-Koung Joeng, Marc Neilson
Annals of Noninvasive Electrocardiology. 2025-05-01 - 24 citationsMeasuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.Wanda Cui, Rodney P Rocconi, Ramya Thota, Richard A Anderson, Suanna S Bruinooge
The Lancet. Oncology. 2023-10-01 - 13 citationsU.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review.Shaily Arora, Preeti Narayan, Gwynn Ison, Tara Berman, Daniel L. Suzman
Clinical Cancer Research. 2021-10-28
Press Mentions
Inavolisib FDA-Approved for Triplet Combination Use for Metastatic Breast CancerJanuary 7th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
